Holen Sie sich die Stockscreener-App
0.00
100.00%
-100.99
Schlusskurs vom Vortag:
$100.99
Offen:
$0
24-Stunden-Volumen:
0
Relative Volume:
0.00
Marktkapitalisierung:
$3.32B
Einnahmen:
$2.32B
Nettoeinkommen (Verlust:
$82.93M
KGV:
0.00
EPS:
2.52
Netto-Cashflow:
$203.54M
1W Leistung:
-100.00%
1M Leistung:
-100.00%
6M Leistung:
-100.00%
1J Leistung:
-100.00%
1-Tages-Spanne:
$0.00
$0.00
1-Wochen-Bereich:
$0.00
$0.00
52-Wochen-Spanne:
$0.00
$101.02
Amedisys Inc Stock (AMED) Company Profile
Firmenname
Amedisys Inc
Sektor
Branche
Telefon
(225) 292-2031
Adresse
3854 AMERICAN WAY, BATON ROUGE, LA
Vergleichen Sie AMED mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AMED
Amedisys Inc
|
0.00 | 3.32B | 2.32B | 82.93M | 203.54M | 2.52 |
|
HCA
Hca Healthcare Inc
|
467.86 | 104.60B | 74.37B | 7.31B | 8.10B | 25.88 |
|
THC
Tenet Healthcare Corp
|
216.17 | 18.59B | 20.69B | 2.40B | 1.55B | 15.62 |
|
FMS
Fresenius Medical Care Ag Adr
|
27.20 | 15.99B | 21.23B | 924.30M | 2.22B | 1.2272 |
|
EHC
Encompass Health Corp
|
127.18 | 12.70B | 5.51B | 494.70M | 386.40M | 4.84 |
|
UHS
Universal Health Services Inc
|
214.03 | 13.41B | 16.08B | 1.20B | 1.06B | 17.82 |
Amedisys Inc Stock (AMED) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-07-29 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2024-07-01 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2023-06-07 | Herabstufung | Truist | Buy → Hold |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2023-03-13 | Eingeleitet | Barclays | Equal Weight |
| 2022-10-27 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2022-08-02 | Herabstufung | UBS | Neutral → Sell |
| 2022-06-29 | Eingeleitet | Stifel | Hold |
| 2022-06-21 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2022-03-01 | Hochstufung | UBS | Sell → Neutral |
| 2022-02-25 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2022-02-25 | Bestätigt | Credit Suisse | Outperform |
| 2022-02-25 | Bestätigt | Oppenheimer | Outperform |
| 2022-02-25 | Bestätigt | RBC Capital Mkts | Outperform |
| 2022-02-25 | Bestätigt | Raymond James | Outperform |
| 2022-02-25 | Bestätigt | Truist | Buy |
| 2021-09-27 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2021-09-24 | Eingeleitet | UBS | Sell |
| 2021-09-10 | Eingeleitet | Cowen | Market Perform |
| 2021-08-10 | Bestätigt | The Benchmark Company | Buy |
| 2021-08-05 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-08-20 | Fortgesetzt | Barclays | Overweight |
| 2020-07-30 | Bestätigt | The Benchmark Company | Buy |
| 2020-06-18 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2020-05-07 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2020-03-09 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2020-01-17 | Eingeleitet | Credit Suisse | Outperform |
| 2019-11-01 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2019-10-22 | Fortgesetzt | Stephens | Equal-Weight |
| 2019-09-17 | Eingeleitet | Deutsche Bank | Buy |
| 2019-05-02 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2018-12-14 | Eingeleitet | Barclays | Equal Weight |
| 2018-11-16 | Eingeleitet | UBS | Neutral |
| 2018-10-30 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2018-07-03 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2018-03-19 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2017-11-09 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2017-11-09 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2017-11-08 | Bestätigt | Mizuho | Buy |
| 2017-11-02 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2017-08-21 | Eingeleitet | BofA/Merrill | Neutral |
Alle ansehen
Amedisys Inc Aktie (AMED) Neueste Nachrichten
How to use Fibonacci retracement on Amedisys Inc.IPO Watch & Long-Term Investment Growth Plans - newser.com
Will Amedisys Inc. stock deliver better than expected guidance2025 Market WrapUp & Accurate Trade Setup Notifications - newser.com
Can Amedisys Inc. stock attract ESG capital inflowsM&A Rumor & Consistent Profit Trading Strategies - Fundação Cultural do Pará
Can swing trading help recover from Amedisys Inc. lossesGDP Growth & Verified Trade Idea Suggestions - newser.com
Long term hold vs stop loss in Amedisys Inc.2025 Fundamental Recap & Accurate Trade Setup Notifications - newser.com
Combining price and volume data for Amedisys Inc.Market Risk Summary & Safe Capital Growth Stock Tips - newser.com
Why pension funds invest in Amedisys Inc. (ADY) stockWeekly Trend Report & Safe Capital Growth Plans - newser.com
Why Amedisys Inc. stock attracts global investors2025 Top Gainers & Reliable Price Breakout Signals - newser.com
Can Amedisys Inc. stock maintain operating marginsJuly 2025 Market Mood & Long-Term Safe Investment Ideas - newser.com
Is Amedisys Inc. stock a defensive play in 2025Portfolio Performance Summary & Low Risk Entry Point Guides - newser.com
How hedge fund analytics apply to Amedisys Inc. stock2025 Technical Overview & Risk Controlled Swing Trade Alerts - newser.com
Will a bounce in Amedisys Inc. offer an exitEarnings Summary Report & AI Driven Price Predictions - newser.com
What Wall Street predicts for Amedisys Inc. stock priceLayoff News & Smart Investment Allocation Insights - newser.com
Is Amedisys Inc. stock gaining market shareMarket Activity Report & Reliable Entry Point Trade Alerts - newser.com
Finanzdaten der Amedisys Inc-Aktie (AMED)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.44%
0.25%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):